Kintz Samuel

Enliven Therapeutics, Inc. · PRESIDENT AND CEO

Kintz Samuel is listed in public filings as director, officer: PRESIDENT AND CEO. This Kintz Samuel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN). Investors use Kintz Samuel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Enliven Therapeutics, Inc.ELVN$267k12.5k sharesSellOct 17, 2025$21.33--
Enliven Therapeutics, Inc.ELVN$74k3.7k sharesSellSep 26, 2025$20.06--
Enliven Therapeutics, Inc.ELVN$56k2.8k sharesSellSep 23, 2025$20.03--
Enliven Therapeutics, Inc.ELVN$20k1k sharesSellSep 19, 2025$20.25--
Enliven Therapeutics, Inc.ELVN$95k5k sharesSellSep 17, 2025$19.09--
Enliven Therapeutics, Inc.ELVN$30k1.5k sharesSellAug 20, 2025$20.00--
Enliven Therapeutics, Inc.ELVN$12k590 sharesSellAug 19, 2025$20.00--
Enliven Therapeutics, Inc.ELVN$208k10.4k sharesSellAug 18, 2025$20.02--
Enliven Therapeutics, Inc.ELVN$106k4.7k sharesSellJul 17, 2025$22.69--
Enliven Therapeutics, Inc.ELVN$90k4.2k sharesSellJul 17, 2025$21.58--
Enliven Therapeutics, Inc.ELVN$86k3.7k sharesSellJul 17, 2025$23.37--
Enliven Therapeutics, Inc.ELVN$232k10.5k sharesSellJun 17, 2025$22.08--
Enliven Therapeutics, Inc.ELVN$45k2k sharesSellJun 17, 2025$22.75--
Enliven Therapeutics, Inc.ELVN$150k7.5k sharesSellJun 3, 2025$20.05--
Enliven Therapeutics, Inc.ELVN$82k5k sharesSellMay 19, 2025$16.49--
Enliven Therapeutics, Inc.ELVN$43k2.2k sharesSellMay 2, 2025$20.00--
Enliven Therapeutics, Inc.ELVN$107k5.3k sharesSellMay 1, 2025$20.08--
Enliven Therapeutics, Inc.ELVN$82k5k sharesSellApr 17, 2025$16.42--
Enliven Therapeutics, Inc.ELVN$260k12.5k sharesSellMar 17, 2025$20.83--
Enliven Therapeutics, Inc.ELVN$28k924 sharesSellOct 18, 2024$30.00--
Enliven Therapeutics, Inc.ELVN$390k13.9k sharesSellOct 9, 2024$28.07--
Enliven Therapeutics, Inc.ELVN$81k2.8k sharesSellOct 9, 2024$28.53--
Enliven Therapeutics, Inc.ELVN$368k13.2k sharesSellOct 8, 2024$27.95--
Enliven Therapeutics, Inc.ELVN$2.9k100 sharesSellOct 8, 2024$28.51--
Enliven Therapeutics, Inc.ELVN$75k2.7k sharesSellOct 7, 2024$27.50--
Enliven Therapeutics, Inc.ELVN$336k12.2k sharesSellOct 4, 2024$27.51--
Enliven Therapeutics, Inc.ELVN$14k526 sharesSellOct 1, 2024$27.54--
Enliven Therapeutics, Inc.ELVN$275k12k sharesSellAug 26, 2024$22.89--
Enliven Therapeutics, Inc.ELVN$63k2.3k sharesSellJul 31, 2024$27.56--
Enliven Therapeutics, Inc.ELVN$205k8.2k sharesSellJul 25, 2024$25.10--
Enliven Therapeutics, Inc.ELVN$1.1k43 sharesSellJul 25, 2024$25.83--
Enliven Therapeutics, Inc.ELVN$93k3.8k sharesSellJul 25, 2024$24.53--
Enliven Therapeutics, Inc.ELVN$247k11.4k sharesSellJun 25, 2024$21.63--
Enliven Therapeutics, Inc.ELVN$13k578 sharesSellJun 25, 2024$22.30--